The p53 tumor suppressor protein functions to monitor the integrity of the genome. If a damage is detected, p53 binds tightly to speci®c sequence elements in the DNA and induces the transactivation of genes involved in various growth regulatory processes such as cell cycle progression, DNA repair and apoptosis. A p53-binding site was recently identi®ed in the promoter region of the metastatic suppressor KAI1 gene, suggesting that this gene was a direct transcriptional target of p53. To test the relevance of this hypothesis, we studied the endogenous KAI1 expression in a series of human cell lines with varying p53 status in response to genotoxic treatment as well as in dierent cellular models exhibiting an inducible p53 activity. Overall, our data indicate that KAI1 expression is not signi®cantly modulated by p53. This observation provides a direct evidence that the presence of a p53-binding site in regulatory domains is not a sucient criteria to de®ne a p53-transcriptional target gene. Oncogene (2000) 19, 2461 ± 2464.
Keywords: p53; KAI1; p53-transcriptional target; DNA damage p53 is the most frequently inactivated tumor suppressor in human cancer (Hainaut et al., 1998) . A variety of mechanisms can lead to such functional inactivation including genetic alteration and interaction with oncogenic viral or cellular proteins. Most p53 mutations that are associated with human cancer aect the central region of the p53 protein that is necessary for speci®c DNA binding. The wild-type p53 protein is indeed a transcription factor that binds in a sequencespeci®c manner to particular sites in the genome and activates transcription of target genes. The consensus for p53 binding site consists of four pentameric repeats of RRRCW in which R is a purine and W represents either an A or a T residue (El-Deiry et al., 1992) . Two palindromic pentamers (half-site) are juxtaposed to a second set palindromic pentamers, the two half-sites being separated by 0 ± 13 bp. Such a consensus site is consistent with the fact that p53 binds to DNA as a tetramer. The p53 pathway can be triggered by cellular stress including DNA damage, hypoxia and oncogene activation (Kastan et al., 1991; Hansen and Oren, 1997) . Induction of p53 leads to cell cycle arrest or apoptosis (Diller et al., 1990; Mercer et al., 1990; Yonish-Rouach et al., 1991) . Although p53 can exhibit transcription-independent functions, numerous studies demonstrated that the transcriptional activating function of p53 is a major component of its biological eects (Crook et al., 1994; Pietenpol et al., 1994) . A substantial number of candidate p53-transcriptional target genes which contain p53-binding sites within their regulatory domains and are transcriptionally activated by wild-type p53 (wtp53) but not by mutant p53 (mp53), have been successively identi®ed. Proteins encoded by these genes are involved in the control of cell division (p21Waf1, 14-3-3s, BTG2...), apoptosis (bax, KILLER/DR5...), DNA repair (GADD45) and angiogenesis (TSP-1). The identi®cation of such genes provided a better insight into molecular mechanisms that allow p53 to act as a cellular gatekeeper for tumoral progression (Levine, 1997) . In this context, the recent suggestion of a direct link between p53 and the KAI1 gene was particularly attracting (Mashimo et al., 1998) . The KAI1 protein belongs to a structurally related family of membrane glycoproteins named transmembrane 4' (TM4) or`tetra spans transmembrane' (TST) family (Boucheix et al., 1991; Wright and Tomlinson, 1994) . Although biological functions of these molecules are unknown, many studies suggest that they are involved in physiological and pathological processes such as cellular adhesion, migration, proliferation, invasiveness and metastasis (Radford et al., 1995; Dong et al., 1995) . The inverse relation observed between their expression levels and the tumor cell ability to metastasize may be functionally linked to their association in multimolecular complexes with extracellular matrix interacting proteins like integrins (Rubinstein et al., 1996; Serru et al., 1999) . In vivo, the KAI1 expression is down-regulated during tumor progression in prostate, lung, pancreatic, breast and liver cancers (Dong et al., 1996; Adachi et al., 1996; Guo et al., 1996 Guo et al., , 1998 Huang et al., 1998) . Experimental overexpression of the gene results in a signi®cant suppression of the cellular metastatic potential (Dong et al., 1995) . Recently, Mashimo and colleagues reported that the p53 protein was able to directly interact with the 5' upstream region of the KAI1 gene (Mashimo et al., 1998) . A sequence exhibiting a signi®cant homology with the p53 consensus binding site was identi®ed at position 7896 to 7863 bp. Electrophoretic mobility shift analysis showed that this sequence indeed had the ability to bind to the puri®ed p53 protein. At last, an induction of endogenous KAI1 gene expression was detected by RT ± PCR 48 h after cellular transfection of a p53 expression plasmid into a human prostatic carcinoma cell line. Although the latter observation may be due to an indirect eect of forced overexpression of p53, these data led to the proposal that KAI1 was a transcriptional target of p53, implying a direct link between a tumor suppressor protein and a metastasis tumor suppressor gene (Mashimo et al., 1998) . To validate this hypothesis we studied the endogenous expression of the KAI1 gene in response to DNA damage in human cell lines with varying functional p53 status.
Wild-type p53 is present in extremely low levels in most cells. In response to DNA damage induced by physical or chemical genotoxic agents, the half-life of p53 is increased and the protein accumulates in the nucleus where it can act as a transcriptional factor (Kastan et al., 1991) . In an eort to test whether KAI1 was positively regulated through a p53-dependent pathway in response to DNA damage, the expression of this gene was studied by Northern blot in a series of human cell lines. The pattern of KAI1 expression was compared with the one of known p53-target genes: p21Waf1 (El-Deiry et al., 1993), BTG2 (Rouault et al., 1996) and 14-3-3s (Hermeking et al., 1997) . MCF-7, HCT116, LNCaP and HepG2 are wtp53 expressing cell lines, derived respectively from human breast, colon, prostate and liver cancers. In all cell lines, expression of p21Waf1, BTG2 and 14-3-3s (data not shown) was induced 1 h after exposure to X-rays (6 Gy) to reach maximal levels after 3 h (see Figure 1 ). This induction was timely correlated to the p53 protein accumulation (Figure 1 ). Basal levels of KAI1 gene expression were easily detectable in MCF-7, HCT116 and LNCaP cells (Figure 1 ). Although at a lesser degree than the three p53-target genes, KAI1 mRNA levels were signi®cantly increased after exposure of these cells to X-rays. However, this induction was a late event (detectable 6 ± 12 h after exposure), exhibiting a signi®cant delay as compared with p53 protein accumulation (Figure 1) . No KAI1 gene overexpression was detected in HepG2 cells after DNA damage. Similar results were obtained by RT ± PCR analysis (data not shown), using conditions previously described (Adachi et al., 1996) . To test whether these observations were speci®c to X-rays, the expression of p21Waf1, BTG2, 14-3-3s and KAI1 was analysed in the four cell lines after exposure to three other types of genotoxic agents: cisplatin (25 mM), UV-C radiation (50 J/m 2 ) and adriamycin (0.1 mg/ml; 0.2 mg/ml and 0.4 mg/ml). In all conditions, an induction of p21Waf1, BTG2 and 14-3-3s expression was observed 3 ± 12 h after treatment (data not shown). Again, the pattern of KAI1 mRNA expression was clearly dierent, with only a weak overexpression in MCF-7, HCT116 and LNCaP cells, 18 h after adriamycin (0.2 and 0.4 mg/ml) treatment (data not shown).
Overall, these observations demonstrated that KAI1 was a DNA damage-inducible gene. However, the kinetic of KAI1 induction was not in favor of a direct role of p53 transcriptional activity. To directly evaluate this role, we analysed KAI1 expression in MCF-7 and HCT116-derived cell lines, exhibiting an inactivation of endogenous p53. MCF-7/MDD2 cells were generated by stably transfecting breast adenocarcinoma MCF-7 cells with a dominant negative p53 miniprotein (Shaulian et al., 1992; Bacus et al., 1996) . This Cterminal segment of p53 forms stable oligomers with endogenous p53, leading to the abrogation of sequence speci®c DNA binding. MCF-7/MN1 cells were generated from MCF-7 cells by transfection of the antibiotic resistance gene alone. Endogenous wtp53 was inactivated in HCT116 by homologous recombination (Bunz et al., 1998) . As expected from previous experiments, p21Waf1 and BTG2 induction after genotoxic treatment was strongly inhibited in MCF-7/MDD2 cells and HCT116 p53(7/7) cells (Figure 2A,B) . In contrast, KAI1 expression was slightly induced in all cell lines 6 ± 12 h after exposure, independently of the p53 functional status.
These experiments suggested that KAI1 induction in response to DNA damage was triggered by a p53-independent pathway. To more directly test the ability of p53 to modulate KAI1, we evaluated KAI1 expression in a human cell line expressing an inducible p53 activity. The human hepatocarcinoma Hep3B cell line was stably transfected by an expression plasmid Figure 1 Induction of KAI1 gene expression in response to DNA damage. To test whether KAI1 was positively regulated through a p53-dependent pathway in response to DNA damage, the expression of KAI1, BTG2, 14-3-3s (data not shown) and p21Waf1 genes was studied by Northern blot in a series of human cell lines. MCF-7, LNCaP and HepG2 cells were maintained in DMEM (Dulbecco's Modi®ed Eagle's Medium) containing 10% fetal calf serum. HCT116 cells were grown in McCoy's medium (Gibco ± BRL, Bethesda, MD, USA) supplemented with 10% fetal calf serum. Cells were exposed to X-irradiation (6 Gy). Cells were collected at indicated times and total cellular RNA was extracted. RNA samples (10 mg) were separated by electrophoresis through denaturing formaldehyde agarose gel and transferred to nylon membranes (Hybond N + ; Amersham). Blots were hybridized with KAI1, p21Waf1 and BTG2 cDNA probes. A probe for GAPDH was used as a control. p53 protein levels were assessed by Western blot analysis, as previously described KAI1 expression after DNA damage C Duriez et al encoding a temperature sensitive (ts) version of mutant p53 (murine p53 val
135
) under the control of a constitutive promoter. After placing Hep3B-tsp53 cells at the permissive temperature (328C), a rapid increase of p21Waf1 and BTG2 mRNA levels was observed after 2 h to reach maximal levels after 8 ± 12 h ( Figure  3) . In similar conditions, KAI1 expression was not signi®cantly aected ( Figure 3) . As control, Hep3B cells were transfected with vector alone. Shifting control cells to 328C did not result in a modulation of KAI1 mRNA steady-state levels demonstrating that reduced temperature by itself does not perturb its expression (data not shown).
Overall, our data strongly suggest that KAI1 gene expression is not regulated through a p53-dependent pathway in response to DNA damage. The KAI1 gene was proposed as a new p53-transcriptional target essentially on the basis of the presence in its promoter region of a sequence that matches the p53-consensus binding site at 17 of 20 positions. In vitro, this sequence is able to bind to the puri®ed p53 protein. A characteristic feature of the p53 binding site is its rather low stringency as only two out of 10 bases of the half-site (C at position 4 and G at position 7) are conserved. The size and degeneracy of these sequences suggest the existence of a large pool of potential p53
Figure 2 KAI1 gene expression in cell lines exhibiting an inactivation of endogenous p53. Following X-irradiation (6 Gy), MN1/ MCF-7 (endogenous wtp53) and MDD2/MCF-7 (inactivated p53) cells (A) as well as HCT116 p53(+/+) and HCT116 p53(7/7) cells (B) were collected at indicated times and total RNA was extracted. Blots were hybridized with KAI1, p21Waf1, BTG2 and GAPDH cDNA probes ). Cells were maintained at non permissive temperature (398C) in Eagle's MEM (Eagle's Minimum Essential Medium) containing 10% fetal calf serum under 0.25 mg/ml G418 selection. Twenty-four hours prior to shifting to p53-permissive temperature (328C) cells were plated at 10 6 cells per 100 mm dish. Total cellular RNA was extracted at indicated times. After electrophoresis and transfer, membranes were hybridized with KAI1, p21Waf1, BTG2 and GAPDH cDNA probes responsive elements with diering sequences and, consequently, the existence of up to several hundred p53-regulated genes. This apparent lack of speci®city is surprising for a protein that plays a crucial role in determining the cellular fate after DNA damage and may suggest the presence of a superior level of regulation. Since p53 interacts with a number of proteins and is subjected to various post-translational modi®cations (Hupp et al., 1992; Takenaka et al., 1995; Resnick-Silverman et al., 1998) , we can not de®nitely discard the possibility that KAI1 may be recruited by p53 in response to speci®c signals and/or in particular cell types. However, the lack of induction in four dierent cell types, in which a downmodulation of endogenous KAI1 during tumor progression was previously demonstrated, strongly suggests that KAI1 is not a primary target of p53. In a more general point of view, our observations demonstrate that the presence in the promoter or intronic regions of a sequence ®tting the consensus binding site is necessary but not sucient to de®ne a direct transcriptional target of p53. This strengthens the following criteria proposed by L Ko and C Prives (Ko and Prives, 1996) : (i) the existence of p53-binding sites that can speci®cally be recognized by p53; (ii) the ability of these sites to act as a p53-response element, activating basal transcription in a wild-type p53 dependent manner; (iii) the response of the element to p53 in the context of the endogenous genomic promoter; (iv) the induction of the target gene after cellular stress, such as DNA damage, in cells containing wild-type but not mutant p53.
